BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8536899)

  • 1. Diagnostic utility of K-ras mutational analysis on bile obtained by endoscopic retrograde cholangiopancreatography.
    Lee JG; Leung JW; Cotton PB; Layfield LJ; Mannon PJ
    Gastrointest Endosc; 1995 Oct; 42(4):317-20. PubMed ID: 8536899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses.
    van Heek NT; Clayton SJ; Sturm PD; Walker J; Gouma DJ; Noorduyn LA; Offerhaus GJ; Fox JC
    J Clin Pathol; 2005 Dec; 58(12):1315-20. PubMed ID: 16311354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples.
    Khalid A; Pal R; Sasatomi E; Swalsky P; Slivka A; Whitcomb D; Finkelstein S
    Gut; 2004 Dec; 53(12):1860-5. PubMed ID: 15542529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases.
    Van Laethem JL; Bourgeois V; Parma J; Delhaye M; Cochaux P; Velu T; Devière J; Cremer M
    Gastrointest Endosc; 1998 Jun; 47(6):479-85. PubMed ID: 9647372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.
    Bartsch D; Bastian D; Barth P; Schudy A; Nies C; Kisker O; Wagner HJ; Rothmund M
    Ann Surg; 1998 Jul; 228(1):79-86. PubMed ID: 9671070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
    Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
    Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
    Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
    J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases.
    Pugliese V; Pujic N; Saccomanno S; Gatteschi B; Pera C; Aste H; Ferrara GB; Nicolò G
    Gastrointest Endosc; 2001 Nov; 54(5):595-9. PubMed ID: 11677475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of K-ras mutation analysis for pancreaticobiliary cytology specimens with indeterminate diagnosis.
    Cai G; Mahooti S; Lipata FM; Chhieng D; Hui P
    Cancer Cytopathol; 2012 Oct; 120(5):313-8. PubMed ID: 22367918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination.
    Yamashita K; Kida Y; Shinoda H; Kida M; Okayasu I
    Jpn J Cancer Res; 1999 Feb; 90(2):240-8. PubMed ID: 10189896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis.
    Sturm PD; Rauws EA; Hruban RH; Caspers E; Ramsoekh TB; Huibregtse K; Noorduyn LA; Offerhaus GJ
    Clin Cancer Res; 1999 Mar; 5(3):629-35. PubMed ID: 10100716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease: a prospective study in more than 100 patients.
    Müller P; Ostwald C; Püschel K; Brinkmann B; Plath F; Kröger J; Barten M; Nizze H; Schareck WD; Hauenstein K; Liebe S; Löhr JM
    Eur J Clin Invest; 2001 Mar; 31(3):240-7. PubMed ID: 11264652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
    Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
    Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnostic testing as an adjunct to morphologic evaluation of pancreatic ductal system brushings: potential augmentation for diagnostic sensitivity.
    Willmore-Payne C; Volmar KE; Huening MA; Holden JA; Layfield LJ
    Diagn Cytopathol; 2007 Apr; 35(4):218-24. PubMed ID: 17351944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma.
    Watanabe H; Ha A; Hu YX; Ohtsubo K; Yamaguchi Y; Motoo Y; Okai T; Toya D; Tanaka N; Sawabu N
    Cancer; 1999 Oct; 86(8):1441-8. PubMed ID: 10526271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocentric study of bile aspiration associated with biliary brushing performed during endoscopic retrograde cholangiopancreatography in 239 patients with symptomatic biliary stricture.
    Fior-Gozlan M; Giovannini D; Rabeyrin M; Mc Leer-Florin A; Laverrière MH; Bichard P
    Cancer Cytopathol; 2016 May; 124(5):330-9. PubMed ID: 26700399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial.
    Trümper L; Menges M; Daus H; Köhler D; Reinhard JO; Sackmann M; Moser C; Sek A; Jacobs G; Zeitz M; Pfreundschuh M
    J Clin Oncol; 2002 Nov; 20(21):4331-7. PubMed ID: 12409332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
    Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
    Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears.
    Apple SK; Hecht JR; Novak JM; Nieberg RK; Rosenthal DL; Grody WW
    Am J Clin Pathol; 1996 Mar; 105(3):321-6. PubMed ID: 8602613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.
    Reicher S; Boyar FZ; Albitar M; Sulcova V; Agersborg S; Nga V; Zhou Y; Li G; Venegas R; French SW; Chung DS; Stabile BE; Eysselein VE; Anguiano A
    Pancreas; 2011 Oct; 40(7):1057-62. PubMed ID: 21705950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.